title: [Pseudomonas stutzeri osteitis: A case study].
abstract: We report a case of osteitis in a 46-year-old patient, caused by Pseudomonas stutzeri following an open fracture of the left femur. The patient was treated with 1g ceftazidime every 8 hours for two weeks combined with 160 mg/day of amikacin for 10 days. A second-line ofloxacin oral treatment at 400 mg/day was then given during 4 weeks. Surgical treatment consisted in debridement of the fracture region. Sterilization of the fracture region led to an osteosynthesis by blade plate and bone graft. The result was favorable.
authors.affiliation: Service de microbiologie, hôpital militaire d'instruction Mohammed-V Rabat, Maroc. elouennassm@yahoo.fr
authors.forename: M
authors.initials: M
authors.lastname: Elouennass
authors.forename: M
authors.initials: M
authors.lastname: Frikh
authors.forename: Z
authors.initials: Z
authors.lastname: Raissouni
authors.forename: T
authors.initials: T
authors.lastname: Bajjou
authors.forename: M
authors.initials: M
authors.lastname: Ouaaline
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002442:Ceftazidime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005264:Femoral Fractures / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D008997:Monobactams / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000175:diagnosis* / Q000188:drug therapy*; D044223:Pseudomonas stutzeri; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D008997:Monobactams; C041078:ceftazidime monobactam; D002442:Ceftazidime